Red cell transfusions: Is less always best?
- 1 June 2021
- journal article
- review article
- Published by Wiley in Transfusion
- Vol. 61 (7) , 2195-2203
Abstract
No abstract availableKeywords
Funding Information
- Haematology Society of Australia and New Zealand
- Monash University
- National Health and Medical Research Council
This publication has 55 references indexed in Scilit:
- Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)Haematologica, 2011
- Objectively measured physical capability levels and mortality: systematic review and meta-analysisBMJ, 2010
- Health economics in haemophilia: a review from the clinician’s perspectiveHaemophilia, 2010
- Assessment of the urgency and deferability of transfusion to inform emergency blood planning and triage: the Bloodhound prospective audit of red blood cell useTransfusion, 2009
- Quality of life and use of red cell transfusion in patients with myelodysplastic syndromes. A systematic reviewAmerican Journal of Hematology, 2009
- Darbepoetin alfa for the treatment of anemic patients with low- and intermediate-1-risk myelodysplastic syndromesAnnals of Oncology, 2005
- Anemia Is Associated with Disability and Decreased Physical Performance and Muscle Strength in the ElderlyJournal of the American Geriatrics Society, 2004
- A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony‐stimulating factor: significant effects on quality of lifeBritish Journal of Haematology, 2003
- Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement systemJournal of Pain and Symptom Management, 1997
- Qualitative Research: Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services researchBMJ, 1995